drugset / Trial / NCT00804193

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

NCT00804193

Completed 553 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Topical Suspension (Test Product) and Ciclopirox Topical Suspension 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and to show the superiority of the active treatments over that of the vehicle.

Timeline

Start
2004-06
Primary completion
2004-12
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclopirox Unknown 0.77 % Topical

Indications